Celcuity (CELC) Other Working Capital Changes (2017 - 2023)
Celcuity's (CELC) quarterly Other Working Capital Changes came in at -$7.7 million in Q4 2025, down 649.17% YoY from $1.4 million in Q4 2024, and down 241.48% on a QoQ basis from $5.4 million in Q3 2025.
Analysis
Celcuity (CELC) Other Working Capital Changes (2017 - 2023) Analysis & Trends
Celcuity (CELC) has 9 years of Other Working Capital Changes data on file, last reported at -$7.7 million in Q4 2025.
- Quarterly Other Working Capital Changes fell 649.17% year-over-year to -$7.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.0 million (up 207.98% YoY) and the FY2025 annual result came in at $3.0 million, up 207.98% from the prior year.
- Other Working Capital Changes retreated to -$7.7 million in Q4 2025, from $5.4 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $5.4 million in Q3 2025 to a low of -$7.7 million in Q4 2025.
- A 5-year average of $479551.8 and a median of $99006.0 in 2021 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes slumped 1801.56% — and 2025, when it jumped 2118.15%.
- Tracing CELC's Other Working Capital Changes over 5 years: stood at $285326.0 in 2021, then sank by 202.11% to -$291356.0 in 2022, then soared by 914.22% to $2.4 million in 2023, then slumped by 143.38% to -$1.0 million in 2024, then tumbled by 649.17% to -$7.7 million in 2025.
- The last three Other Working Capital Changes figures came in at -$7.7 million (Q4 2025), $5.4 million (Q3 2025), and $2.8 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Celcuity | 5.25 Bn | 5.25 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -64,212.00 |
| Jun 30, 2023 | -64,212.00 |
| Mar 31, 2023 | 181,211.00 |
| Mar 31, 2023 | 181,211.00 |
| Dec 31, 2022 | -234,095.00 |
| Dec 31, 2022 | -234,095.00 |
| Sep 30, 2022 | 1.98 Mn |
| Sep 30, 2022 | 1.98 Mn |
| Jun 30, 2022 | 3.84 Mn |
| Jun 30, 2022 | 3.84 Mn |
| Mar 31, 2022 | 40,205.00 |
| Mar 31, 2022 | 40,205.00 |
| Dec 31, 2021 | 285,326.00 |
| Dec 31, 2021 | 285,326.00 |
| Sep 30, 2021 | 157,807.00 |
| Sep 30, 2021 | 157,807.00 |
| Jun 30, 2021 | -271,801.00 |
| Jun 30, 2021 | -271,801.00 |
| Mar 31, 2021 | 234,305.00 |
| Mar 31, 2021 | 234,305.00 |